On June 10, Potiga (ezogabine) tablets were approved by the U.S. Food and Drug Administration for use as an add-on medication to treat seizures associated with epilepsy in adults. ivermectin clinical trial covid
Potiga was approved for the treatment of partial seizures, the most common type of seizure seen in people with epilepsy.
